SELLAS Life Sciences (SLS) Current Assets (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Current Assets for 9 consecutive years, with $24.0 million as the latest value for Q3 2024.
- Quarterly Current Assets rose 361.95% to $24.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $24.0 million through Sep 2024, up 361.95% year-over-year, with the annual reading at $3.2 million for FY2023, 82.14% down from the prior year.
- Current Assets for Q3 2024 was $24.0 million at SELLAS Life Sciences, up from $12.3 million in the prior quarter.
- The five-year high for Current Assets was $36.9 million in Q4 2020, with the low at $3.2 million in Q4 2023.
- Average Current Assets over 5 years is $19.6 million, with a median of $21.5 million recorded in 2024.
- The sharpest move saw Current Assets skyrocketed 561.22% in 2021, then plummeted 82.14% in 2023.
- Over 5 years, Current Assets stood at $36.9 million in 2020, then plummeted by 37.59% to $23.0 million in 2021, then dropped by 22.95% to $17.8 million in 2022, then plummeted by 82.14% to $3.2 million in 2023, then skyrocketed by 657.72% to $24.0 million in 2024.
- According to Business Quant data, Current Assets over the past three periods came in at $24.0 million, $12.3 million, and $21.5 million for Q3 2024, Q2 2024, and Q1 2024 respectively.